Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02232659Not ApplicableUnknown

SynCardia 70cc TAH-t for Destination Therapy (DT)

Role: lead

NCT01919320Unknown

SynCardia Companion 2 Driver System Post Approval Study Protocol With INTERMACS™-Based Data Collection

Role: lead

NCT02459054Not ApplicableTerminated

Syncardia 50cc TAH-t as a Bridge to Transplant

Role: lead

NCT00733447Unknown

SynCardia Freedom Driver System Study

Role: lead

NCT00614510Completed

SynCardia CardioWest TAH-t Postmarket Surveillance Study

Role: lead

All 5 trials loaded